ReviewPharmaceuticals (Basel, Switzerland)2026
Endophyte-Mediated Green Synthesis of Metallic Nanoparticles: Mechanistic Insights, Antibiofilm Efficacy, and Translational Challenges.
Review in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance, a major health problem for the world's population, is caused by pathogenic bacteria capable of forming biofilms, claiming 4.95 million lives each year, according to WHO (World Health Organization) data, and could escalate up to 10 million annual deaths by 2050 if unchecked. Biofilms are the structured microbial populations surrounded and composed by an EPS (Extracellular Polymeric Substance) matrix to protect themselves from host immune responses and antibiotics, which makes the infections persistent and difficult to treat. Current global approaches to the pathogenic microbes to address AMR (Antimicrobial Resistance) are solved by different alternative strategies; one such strategy is nanotechnology, a rapidly developing field in the twenty-first century, using metallic nanoparticles that are generally characterized by dimensions within the range of 1-100 nm, have distinct structural and functional properties from bulk materials, and perform higher penetration in the cell membranes of pathogenic microbes. Overall, the present review offers a detailed overview of significant knowledge gaps regarding scalability, long-term safety, and the mechanistic pathway of nanoparticles synthesized from endophytic microorganisms. The inclusion also summarizes a comparison of bacterial and fungal endophyte-mediated metallic nanoparticles with plant-mediated metallic nanoparticles, particularly in terms of metabolite diversity, synthesis efficiency, size, nanoparticle stability, toxicity, antimicrobial activity, and antibiofilm potential. The novelty lies in how the efficacy of endophytic-mediated metallic nanoparticles acts against the defense mechanisms of pathogenic microorganisms in terms of molecular pathways and processes associated with ROS (Reactive Oxygen Species), disruption of membrane integrity, quorum sensing interference, EPS (Extracellular Polymeric Substance) degradation, DNA and protein disruption, and biofilm collapse. However, nanoparticles synthesized from endophytic microorganisms face translational challenges and limitations that need to be addressed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.